Connect with us

National

AstraZeneca pauses vaccine trial after suspected adverse event – Financial Times

Drugmaker puts study of Covid-19 jab on hold to allow it to ‘review safety data’

Published

on

post featured image

AstraZeneca has paused all clinical trials of the Covid-19 vaccine it is developing with Oxford university after a participant in the UK arm of the study suffered a suspected serious adverse reaction.
The UK-based drugmaker voluntarily put the trial on hold after the discovery of the sick participant. AstraZeneca said it was working to review the event to ensure it would not result in a significant delay to the study.
AstraZeneca had been on track to become one of the first drugmakers to del…

Click here to view the original article.